Potassium Hydroxide → HCID 53731832, compound
Reaction equation
[CH2:1]([S:8][C@H:9]1[NH:12][C:11](=[O:13])[C@@H:10]1[Br:14])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:15]1([CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][NH:27][C:28](=[O:31])[CH2:29]Br)[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1.[OH-].[K+].[OH-].C([N+](CCCC)(CCCC)CCCC)CCC>C1COCC1>[C:15]1([CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][NH:27][C:28](=[O:31])[CH2:29][N:12]2[C@H:9]([S:8][CH2:1][C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=3)[C@@H:10]([Br:14])[C:11]2=[O:13])[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1Participants
Procedure
A solution of (3S, 4R)-4-benzylthio-3-bromoazetidin-2-one (0.7 g, 2.6 mmol) in dry THF (25 ml) was treated with N-(6-phenylhexyl)bromoacetamide (0.8 g, 2.6 mmol), powdered potassium hydroxide (0.2 g 3 mmol) and tetrabutylammonium hydroxide (0.1 g, 0.3 mmol). The mixture was stirred at room temperature for 4 h and partitioned between ether and brine. The organic layer was separated, dried (MgSO4) and evaporated. The residue was purified by flash chromatography using 3:1 ether:pentane as the eluting solvent. Evaporation of the appropriate fractions gave the title compound as an oil (0.63 g, 53%). 1H NMR δ (CDCl3) 1.21-1.66 (8H, m, (CH2)4), 2.59 (2H, t, J=7.4 Hz, CH2), 3.48,3.82 (each 1H, d, J=16 Hz, NCH2), 3.21 (2H, h, J=6.00 Hz, CH2), 3.37 (1H, dd, J=5.15 Hz, H3b), 3.83 (2H, s, SCH2), 4.59 (1H, d, J=1.6 Hz, H4), 4.89 (1H, d, J=1.6 Hz, H3), 6.04 (1H, bt, NH), 7.14-7.36 (10H, m, Ph--H).
Workup
- custompartitioned between ether and brine
- customThe organic layer was separated
- dry with materialdried (MgSO4)
- customevaporated
- customThe residue was purified by flash chromatography
- customEvaporation of the appropriate fractions
Sources & evidence
- ORD record
- ord-b51b8f356b6b4f479311bff0f0a3b728
- Source dataset
- uspto-grants-1999_11
- Patent number
- US05990102
Reaction notes
Loading…